© 2020 MJH Life Sciences and HCPLive. All rights reserved.
© 2020 MJH Life Sciences™ and HCPLive. All rights reserved.
October 09, 2020
The Arbor Pharmaceutical drug is aimed at treating ADHD without being manipulated for non-oral use.
ELP Pharma readying plans to continue to study the drug in a phase 3 trial.
October 08, 2020
There was also a decline depression care in recent years among adolescents and young adults.
A virtual reality platform could enable ADHD patients to improve cognitive functioning.
October 07, 2020
Paul Christo, MD, discusses opioid addiction during the pandemic, the role of the clinician, and offers a hopeful outlook for the future.
Experts expect an increase in mental health issues caused by the pandemic in the future.
October 06, 2020
Medication might be best used as a first-line option for patients with ADHD.
An expert discusses trends in pediatric mental health and receipt of treatment.
October 02, 2020
Higher levels of acetaminophen detected in meconium was linked to increased odds of developing ADHD by 6-7 years old.
October 01, 2020
There could be a lasting impact caused by some of the changes due to the pandemic.